We are happy to announce that our long-term client and trusted partner, Greene Street Pharmaceuticals LLC, strengthened our business relationship today by appointing us as their exclusive API sourcing partner.

The Pennsylvania-based company specializes in #transdermal delivery systems with the vision to make a meaningful impact on patients’ lives. Greene Street utilizes Quinta-Analytica’s API Solution services for multiple projects and is able to leverage the partnership to ensure a high level of continuity and expand their offering beyond the scope of their core service provision.

This is yet another recognition of Quinta’s world-class API Solutions program, which supports partners from all geographies and backgrounds with our robust services – now and into the future!

Additional News

  • 16 December 2024

    Welcome, 2025!

    Reflecting on 2024 with gratitude and looking ahead with optimism.

  • 2 December 2024

    A Decade of Partnership with Adamed Pharma

    Adamed Pharma and Quinta-Analytica’s 10 – Year Journey in Pharma Innovation

  • 25 November 2024

    Expediting Biosimilar development: Streamlining the path from research to market

    On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.